Showing results (841-850 of 985) with videos related to
Sort By:
Pageof 99
Journal of Orthopaedic Trauma|January 23, 2024
The Impact of Smoking on Hospital Course and Postoperative Outcomes in Patients With Fracture-Related InfectionsEvan G Gross, Zuhair Mohammed, Karen J Carter, et al.Pediatric Research|October 1, 1995
X-linked lymphoproliferative disease: twenty-five years after the discoveryT A Seemayer, T G Gross, R M Egeler, et al.Beneficial Microbes|May 22, 2026
Infant gut microbiota composition and metabolism can be influenced by extensively hydrolysed casein in vitroG Gross, I Bobeldijk-Pastorova, A M T Ouwens, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 2018
Discs large 1 controls daughter-cell polarity after cytokinesis in vertebrate morphogenesisYuwei Li, Jason A Junge, Cosimo Arnesano, et al.The Journal of Investigative Dermatology|October 9, 1998
Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancerS Stark, A K Petridis, S J Ghim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2022
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1Eric J Lowe, Anne F Reilly, Megan S Lim, et al.Eksperimental'Naia I Klinicheskaia Farmakologiia|May 25, 2002
[Stimulation of delta1-opioid receptors increases the ventricular fibrillation threshold in post-infarct cardiosclerosis: the role of K(ATP)-channels]N V Solenkova, L N Maslov, Iu B Lishmanov, et al.Transplantation|April 17, 2003
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainmentStephen L Guthery, James E Heubi, John C Bucuvalas, et al.Seminars in Pediatric Surgery|July 5, 2006
Malignancy in pediatric transplant recipientsJoseph F Buell, Thomas G Gross, Mark J Thomas, et al.Pediatric Blood & Cancer|September 26, 2008
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupTimothy C Griffin, Sheila Weitzman, Howard Weinstein, et al.Pageof 99